𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antibody response to embryonal carcinoma cells in syngeneic mice

✍ Scribed by Marline Damonneville; Dominique Morello; Gabriel Gachelin; Marc Stanislawski


Publisher
John Wiley and Sons
Year
1979
Tongue
English
Weight
668 KB
Volume
9
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Primary antibody responses to hapten-mod
✍ Izumi Nakashima; Munehisa Takashi; Fumihiko Nagase; Nobuo Kato 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB

## Abstract Intravenous injection of fluorescein isothiocyanate‐modified syngeneic spleen cells (FITC‐SSC) into mice induced T cell‐independent, anti‐hapten plaque‐forming cell responses. In contrast to the high immunogenicity of FITC‐coupled SSC or bone marrow cells, thymus, lymph node or peritone

Spontaneous mammary carcinomas fail to i
✍ Robert A. Kurt; Rachel Whitaker; Anjelo Baher; Steven Seung; Walter J. Urba 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 148 KB

FVBN202 mice, which are transgenic for the rat neu gene, spontaneously develop mammary carcinomas between 6 and 7 months of age. We investigated whether these spontaneous tumors (spontaneous breast carcinoma cells, SBCC) could elicit an immune response in naive 6-to 8-week-old FVBN202 transgenic and

Cell-mediated responses to tumour xenogr
✍ Elizabeth Simpson; P. C. L. Beverley 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 French ⚖ 416 KB

## Abstract A micro‐cytotoxic assay has been used to follow the course of the cell‐mediated response to a tumour xenograft in normal and ALS‐treated mice. In normal mice a peak response was seen at day 10 in both lymph nodes and spleen. Further peaks of cytotoxic activity were seen at days 18 and 4

The effect of antibody protein dose of a
✍ Marion H. G. C. Kranenborg; Otto C. Boerman; Mirjam C. A. de Weijert; Jeannette 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

## RESULTS. The relative uptake of G250 in NU-12 tumors was very high at low protein doses (125% injected dose/g [%ID/g]), but decreased at higher doses, suggesting